RMIT University
Browse

Effectiveness of qigong and Tai Chi for quality of life in patients with cancer: an umbrella review and meta-analysis

Download (2.05 MB)
journal contribution
posted on 2025-04-16, 23:26 authored by Jing Xu, Hong LiHong Li, Daniel Man-yuen Sze, Vincent ChanVincent Chan, Angela YangAngela Yang

Background

Qigong and Tai Chi (QTC) have been adopted by cancer patients as the complementary treatment to their conventional care. This umbrella review aimed to evaluate the clinical effectiveness of QTC in cancer patients’ quality of life (QoL) and its safety.

Methods

Twenty-five databases were searched from their respective inception to March 2025. Systematic reviews (SRs) and meta-analyses of randomized controlled trials (RCTs) assessing cancer patients’ QoL after practicing QTC were included. The search strategy included Qigong, Tai Chi, quality of life, cancer, systematic review, and meta analysis. The extracted data was analyzed using standardized mean difference, mean difference, or odds ratio with 95% confidence intervals.

Results

Nine SRs were included in the qualitative analysis, and six of the SRs were included for the meta-analyses. Results showed that QTC may improve cancer patients’ overall QoL, physiological scores (physical functioning, fatigue, and sleep quality), psychological scores (mental health and anxiety), and immunity, compared to the control groups. However, meta-analyses did not demonstrate significant differences in subgroup analyses of depression, although it showed that QTC may reduce depression in cancer patients. No serious adverse events of QTC were reported.

Conclusion

QTC can be considered a safe intervention method for improving QoL in patients with cancer. Due to substantial heterogeneity, more rigorously-designed RCTs on QTC for cancer patients should be conducted, focusing on standardizing QTC practices and QoL instruments to assess QTC effects.

History

Journal

BMC Complementary Medicine and Therapies

Volume

25

Number

141

Issue

1

Publisher

Springer Science and Business Media LLC

Language

en

Copyright

© 2025, The Author(s)

Usage metrics

    Scholarly Works

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC